United States · FDA National Drug Code directory
Fexofenadine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62207-765_5447dc7c-b363-56c6-e063-6294a90a729d
- Product NDC
- 62207-765
- Form
- TABLET
- Composition / generic term
- Fexofenadine Hydrochloride
- Labeler
- Granules India Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201218
- Source listing expiry
- 20271231
Source-listed ingredients
- FEXOFENADINE HYDROCHLORIDE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (62207-765-49) · 62207-765-49
- 1 BOTTLE in 1 CARTON (62207-765-51) / 10 TABLET in 1 BOTTLE · 62207-765-51
- 8 BLISTER PACK in 1 CARTON (62207-765-60) / 9 TABLET in 1 BLISTER PACK · 62207-765-60
- 5 POUCH in 1 BOX (62207-765-88) / 10000 TABLET in 1 POUCH · 62207-765-88
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →